Prostate Cancer Clinical Masterclass Series Clinical Comms Group

Welcome to this bonus episode in the Prostate Cancer Clinical Masterclass Series. This is an independent educational initiative organised by The Clinical Comms Group.

In today’s episode our co-chiars, Sumit Subudhi and Gerhardt Attard, will summarise some of the opportunities and challenges they believe will be important in the next 1 to 2 years for prostate cancer treatment.

This month we are joined by Dr Joshua Lang, from the University of Wisconsin Carbone Comprehensive Cancer Center, Madison, who will present on the very current topic of ‘Metastatic Niche and Treatment Resistanc’. We will also hear from Prof Andrea Alimonti, from the Institute of Oncology Research, Bellinzona, who will help to add clarity around the fascinating topic of ‘Role of Microbiome in Treatment Resistance’. It is co-chaired by Dr Gerhardt Attard, from University College London, who leads the group disucssion to close the episode.

This month we are joined by Dr Lorelei Mucci, from the Harvard School of Public Health, Massachusetts, who will present on the very current topic of ‘Disparities in Ethnic Minorities’. We will also hear from Prof Derek Rosario, from Sheffield Teaching Hospitals, Sheffield, who will help to add clarity around the very current question of ‘Is There a Role for Diet and Exercise?’. It is co-chaired by Dr Gerhardt Attard, from University College London, U.K., who leads the group disucssion to close the episode.

This month we are joined by Prof Stacy Loeb, from NYU Langone Health and the Manhattan Veterans Affairs, who presents on ’Sleep Dysfunction in Prostate Cancer’. We will also hear from Prof Silke Gillessen, from the USI and the IOSI in Switzerland, who will present updates on the topic ’Tumour Metabolism as a Driver and Treatment Target’. It is co-chaired by Dr Sumit Subudhi, from MD Anderson Cancer Center, Houston, Texas, who leads the group disucssion to close the episode.

This month we are joined by Dr Osama Mohamad, from University of California, San Francisco, who will help to add clarity around the very current question of ‘Will Artificial Intelligence Ever Substitute for Pathologists?’. We will also hear from Prof Alicia Morgans, from Dana-Farber Cancer Institute, Massachusetts, who will present her thoughts on the topic of ’Strategies for Survivorship’. It is co-chaired by Dr Gerhardt Attard, from University College London, U.K., who leads the group disucssion to close the episode.

This month we are joined by Prof Samuel Denmeade, from the Johns Hopkins University School of Medicine, who gives a fascinating overview on research into ’Bipolar Testosterone Therapy’. This episode is co-chaired by Dr Sumit Subudhi, from MD Anderson Cancer Center, Houston, Texas, who leads the disucssion to close the episode.